Effect of Four Crystalloid Cardioplegias on Immature Rabbit Hearts During Global Ischaemia  by Mei, Yunqing et al.
ASIAN JOURNAL OF SURGERY  VOL 29 • NO 2 • APRIL 2006 79
070/2001
Original Article
© 2006 Elsevier. All rights reserved.
Effect of Four Crystalloid Cardioplegias on
Immature Rabbit Hearts During Global Ischaemia
Yunqing Mei, Hua Liu, Cun Long, Bangchang Cheng, Shangzhi Gao and Dayi Hu, Department of
Thoracic Cardiovascular Surgery, The Affiliated Tongji Hospital of Tongji University, Shanghai, China.
OBJECTIVE: Controversy surrounds the reported beneficial effects of crystalloid cardioplegic solutions in the
immature myocardium. In the present study, we investigated the efficacy of four clinical cardioplegic solutions
in the immature myocardium to determine if cardioplegic protection could be demonstrated and, if yes, the
relative efficacy of the four solutions.
METHODS: Isolated, working hearts (n = 6 per group) from neonatal rabbits (age, 7–14 days) were perfused
aerobically (37°C) for 15 minutes in the Langendorff mode and 30 minutes in the working mode before a 2-
minute infusion of one of four cardioplegic solutions: the modified St. Thomas’ Hospital no. 1 cardioplegic
solution, Tyers solution, Bretschneider solution or Roe solution. Hearts were then rendered globally ischaemic
for 120 minutes at 14°C before reperfusion for 15 minutes in the Langendorff mode and 30 minutes in the
working mode. The post-ischaemic recovery of cardiac function and leakage of myocardial enzymes (GOT,
CK, CK-MB, LDH, LDH1) were compared with results in noncardioplegic control hearts.
RESULTS: Good protection was observed with modified St. Thomas’ Hospital and Tyers solutions: post-
ischaemic recovery of cardiac output was increased from 80.43 ± 3.62% in the noncardioplegic group to
85.19 ± 3.12% and 70.66 ± 3.48% in the St. Thomas’ Hospital and Tyers groups (p < 0.05), respectively. In contrast,
no obvious protection was observed with either the Bretschneider or Roe solutions: cardiac output recovered
to 45.08 ± 3.16% and 30.06 ± 2.59%, respectively. Post-ischaemic CK leakage was 19.83 ± 2.14 IU/mL and 21.17 ±
2.32 IU/mL in the St. Thomas’ Hospital and Tyers groups (p > 0.05). In the Bretschneider group, CK leakage
increased to 30.00 ± 3.16 IU/mL (p < 0.01 vs. noncardioplegic control hearts), and in the Roe group, CK leakage
was 31.00 ± 5.10 IU/mL (p < 0.05 vs. cardioplegic-free hearts). Post-ischaemic ATP was 1.98 ± 0.54 μmol/g•dry
weight and 1.35 ± 0.39 μmol/g•dry weight in the St. Thomas’ Hospital and Tyers groups (p < 0.01 vs. noncardio-
plegic control group), respectively. In the Bretschneider group, ATP decreased to 0.91 ± 0.16 μmol/g•dry weight
(p < 0.05 vs. noncardioplegic control hearts), and in the Roe group to 0.88 ± 0.10 μmol/g•dry weight (p < 0.01 vs.
cardioplegic-free hearts).
CONCLUSION: In conclusion, cardioplegic protection can be achieved in the immature rabbit myocardium
with both St. Thomas’ Hospital and Tyers solutions, but acalcaemic solutions such as Bretschneider and Roe
solutions increased damage. The reported lack of cardioplegic efficacy in the immature myocardium may,
therefore, reflect the choice of cardioplegic solution rather than a greater vulnerability to injury in the neonatal
heart. [Asian J Surg 2006;29(2):79–85]
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Introduction
Although the tolerance of immature myocardium to ischae-
mia is greater than that of mature myocardium, inadequate
protection by crystalloid cardioplegia(s) for immature myo-
cardium has been cited as one of the major reasons for post-
operative deaths in children.1 The interpretation of studies
of cardioplegic efficacy in the immature myocardium are
complicated by the variety of animal species and the range
of different cardioplegic solutions used, and different hypo-
thermias. Therefore, considerable controversy surrounds the
ability of cardioplegic solutions to protect the immature
myocardium.2–6 St. Thomas’ Hospital no. 2 cardioplegic solu-
tion could not confer good protection on immature hearts.3,7
Robinson and his colleagues reported that different crystal-
loid cardioplegias have different effects on mature hearts.8
However, comparative studies by a single investigator have
not been reported for the immature myocardium. Therefore,
in the present study, we used the isolated, working neonatal
rabbit heart to determine if comparable protection afforded
by a variety of crystalloid cardioplegic solutions can, in fact, be
demonstrated in the immature myocardium so as to afford
theoretical evidence for their clinical use. Three major indices
of myocardial injury and protection — functional recovery,
creatine kinase (CK) and adenosine triphosphate (ATP) pre-
servation — were used to compare the efficacy of modified St.
Thomas’ Hospital no. 1, Tyers, Bretschneider and Roe cardio-
plegic solutions.
Materials and methods
Immature New Zealand white rabbits (7–14 days old) were
obtained from a Pasteurella-free breeding colony within The
Peking Union Medical College. Animals used in this study
received humane care in compliance with the Principles of
Laboratory Animal Care formulated by the National Society
for Medical Research and the Guide for the Care and Use of
Laboratory Animals prepared by the National Academy of
Sciences).
Heparin (150 IU/kg) was administered intraperitoneally
before anaesthetization. Anaesthesia was induced and main-
tained with natrium pentobarbital (50 mg/kg). The chest was
opened by a median sternotomy and the heart was rapidly
excised and placed in ice-cold perfusion medium. The time
taken from opening the chest to excision of the heart was 1–2
minutes. Immediately after excision of the heart, the aorta was
cannulated, and Langendorff perfusion was initiated for a
15-minute Langendorff mode period, during which the left
atrium was cannulated. The heart was then converted to a
working preparation by blocking the Langendorff perfusion
line and initiating left atrial perfusion. The heart was per-
fused in the working mode for 30 minutes, during which
control values for aortic flow, coronary flow (timed collection),
and heart rate were recorded. The maximum rates of rise and
fall of aortic pressure (±dp/dtmax) were recorded by means of
a transducer connected to the aortic cannula and electrically
derived. Cardiac output was calculated from the sum of the
aortic and coronary flows, and stroke volume was calculated
by dividing cardiac output by heart rate.
After the 30-minute aerobic control period, the atrial and
aortic lines were blockaded and cardioplegic solution was
infused into the coronary vasculature through a side arm
of the aortic cannula. Infusion was maintained for 2 minutes
at a pressure equivalent to 60 cmH2O. The cardioplegia line
was then blockaded and global ischaemia maintained for
120 minutes at 14°C. The compositions of the Krebs-Henseleit
(KH) buffer and four cardioplegic solutions used are given in
Table 1.
After 120 minutes of ischaemia, the hearts were reperfused
for 15 minutes in the non-recirculating Langendorff mode,
during which time coronary effluent was collected and taken
for the determination of enzyme leakage. The preparation was
then again converted to the working mode for 30 minutes,
at the end of which the recovery of cardiac function was
assessed. At the conclusion of each experiment, the hearts were
removed from the perfusion apparatus, lightly blotted, and
stored under liquid nitrogen (–196°C) for related determina-
tion of indices.
Perfusion media
The standard perfusion medium used was KH buffer (pH 7.4
at 37°C and pH 7.2 at 14°C when gassed with 95% oxygen
and 5% carbon dioxide). During the preparation of all calcium-
containing solutions, the solution was gassed with 5% carbon
dioxide to prevent the precipitation of calcium. All perfusion
fluids were filtered through cellulose acetate membranes with
pore size 0.20 μm.
Measurement of indices
Aortic flow and coronary flow were defined by timed collec-
tions into a container. Electrical activity and heart rate were
measured with bipolar electrocardiographic leads attached
to the aortic and atrial cannulas. Myocardial ATP was assessed
with high-performance liquid chromatography (unit is μmol/
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g•dry weight), a spectrophotometer was used for glycogen,
visible radiation and ultraviolet light spectrophotometer
was used for membrane Na+K+-ATPase (units are mmol/g and
nmol.Pi/mg•pr•min, respectively), the barbital method for
maldihydrate (μmol/g), and self-biochemical detector for
myocardial enzymes (IU/mL).
Perfusion sequence
The following experiments were performed in a random
manner in five groups. Immediately after aortic cannulation,
the hearts were perfused in the Langendorff mode for a
15-minute stabilization period, during which the left atrium
was cannulated. The hearts were then converted to a working
preparation for 30 minutes. During this time, control values
for aortic flow, coronary flow, and heart rate were recorded
under steady-state conditions. This was followed by a single
2-minute period of hypothermic (14°C) coronary perfusion
in the Langendorff mode, with KH buffer serving as the con-
trol group (group D0, n = 6), or with modified St. Thomas’
Hospital no. 1 cardioplegic solution (group D1, n = 6), Tyers
(group D2, n = 6), Bretschneider (group D3, n = 6) or Roe
(group D4, n = 6) cardioplegic solutions. Hearts were subjected
to hypothermic global ischaemia (14°C) for 120 minutes.
The perfusion pressure was 60 cmH2O. The dose of “cardio-
plegia” was 15–20 mL/kg, except for Bretschneider, which
was 50 mL/kg. After the ischaemic period, hearts were reper-
fused for 15 minutes in the Langendorff mode. Hearts were
then converted to the working mode for 30 minutes, during
which time the various indices of function were measured
under steady-state conditions and were expressed as a per-
centage of the pre-ischaemic control values; each heart served
as its own control.
Statistical analysis
Data were expressed as the mean ± standard deviation of
the mean (}X ± S). Statistical analysis was performed initially
with Students’ t test, and then with ANOVA for intergroup
comparisons. Significance was set at the p < 0.05 level.
Results
Haemodynamics
The results are shown in Tables 2 and 3. There were no signi-
ficant differences among the pre-ischaemic haemodynamics
(p > 0.05) of the five groups. The post-ischaemic haemodyna-
mics of aortic flow, coronary flow, and cardiac output were
Table 1. Composition of Krebs-Henseleit bicarbonate buffer (KH) and the four cardioplegic solutions
Component (mmol/L) KH MST Tyers Bretschneider Roe
NaCl 118.5 144.0 88.0 15.0 27.0
KCl 4.8 20.0 5.0 9.0 20.0
MgCl2 – 16.0 1.5 4.0 1.5
CaCl2 1.8 2.4 0.5 – –
NaHCO3 25.0 – – – –
KHCO3 – – 20.0 – –
Na acetate – – 27.0 – –
Na gluconate – – 23.0 – –
Histidine – – – 180.0 –
Histidine HCl – – – 18.0 –
Mannitol – – – 30.0 –
Tryptophan – – – 2.0 –
_-ketoglutarate – – – 1.0 –
MgSO4•7H2O 1.8 – – – –
KH2PO4 1.2 – – – –
Glucose 11.0 – – – 278.0
THAM – – – – 1.0
pH 7.4* 7.2 7.8 7.1 7.6
Osmolality (mOsm/L) 320 320 332 327 378
*The pH of KH is 7.4 when gassed with mixed gases (oxygen:carbon dioxide = 95%:5%) at 37°C. MST = St. Thomas’ Hospital no. 1;
THAM = tris(hydroxymethyl)aminomethane.
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markedly lowered in all groups, and the heart rate was slowed
in groups D3 and D4 (p < 0.05). There were no changes in aortic
pressure (±dp/dtmax) after reperfusion except in group D4 (p <
0.01).
Change in myocardial biochemical indices and
enzyme leakage
All biochemical indices changed significantly (p < 0.01) ex-
cept for Na+K+-ATPase in group D3 and glycogen in group D1
(Table 4).
There were no significant changes in myocardial enzyme
leakage in groups D1 and D2 compared with group D0. How-
ever, there were statistically significant differences in enzyme
leakage in D3 and D4 compared with D0 (p < 0.05) (Table 5).
Discussion
The effects of formulation and the physicochemical character-
istics of cardioplegic solutions on myocardial protection are
substantial. The responsiveness of age-related changes of
hearts to ischaemia and crystalloid cardioplegias also greatly
affect the protection effect. Yamamoto et al found that the
effect of St. Thomas’ Hospital no. 2 cardioplegic solution on
the adult heart manifests the relation of dose-effect to con-
centrations of calcium and magnesium in the cardioplegia,
and Tyers conferred poor protection on the adult rat heart.9
The results of our present study demonstrated that crystal-
loid cardioplegias can indeed confer satisfactory protection
on immature rabbit hearts subjected to hypothermic ischae-
mic arrest at 14°C. However, the extent of protection and,
hence, the post-ischaemic recovery of function, is highly de-
pendent on the composition of the solution used. Although
St. Thomas’ Hospital and Tyers solutions conferred excellent
protection on the immature myocardium in this mode, the
Bretschneider and Roe solutions were ineffective. These re-
sults derived from immature rabbit hearts are different from
the results of crystalloid cardioplegias on adult hearts. The
reasons underlying these differences in cardioplegic efficacy
probably include age-related changes in cardiac metabolism,
and the way in which components of these solutions interact
Table 2. Pre-ischaemic haemodynamics of isolated perfused rabbit hearts (}X ± S)
Haemodynamics
HR AF CF CO +dp/dtmax –dp/dtmax SV
(bpm) (mL/min) (mL/min) (mL/min) (kPa/sec) (kPa/sec) (μL/beat)
Group
D0 232.7 ± 11.7 24.4 ± 1.6 9.6 ± 0.9 34.0 ± 1.5 108.1 ± 3.8 85.0 ± 5.9 146.7 ± 14.4
D1 235.8 ± 9.40 27.7 ± 2.2 9.3 ± 0.5 37.0 ± 2.5 104.2 ± 2.0 82.9 ± 1.9 157.5 ± 15.8
D2 236.0 ± 10.2 24.8 ± 2.4 9.9 ± 1.5 33.9 ± 1.5 102.1 ± 2.6 79.8 ± 4.4 148.4 ± 13.1
D3 240.2 ± 10.5 24.5 ± 2.0 11.1 ± 1.20 35.6 ± 3.1 099.2 ± 3.3 81.0 ± 0.9 148.8 ± 19.3
D4 237.8 ± 6.00 22.5 ± 3.1 10.3 ± 1.70 32.8 ± 3.2 097.8 ± 4.5 81.4 ± 1.5 138.0 ± 16.8
HR = heart rate; AF = aortic flow; CF = coronary flow; CO = cardiac output; SV = stroke volume.
Table 3. Post-ischaemic haemodynamics of isolated perfused rabbit hearts (%, }X ± S)
Haemodynamics
HR AF CF CO +dp/dtmax –dp/dtmax SV
(bpm) (mL/min) (mL/min) (mL/min) (kPa/sec) (kPa/sec) (μL/beat)
Group
D0 99.06 ± 3.43 78.23 ± 3.45
† 78.98 ± 1.97† 80.43 ± 3.62† 83.75 ± 2.16 77.04 ± 4.14 79.25 ± 4.32†
D1 95.95 ± 4.00 85.86 ± 6.22* 83.89 ± 3.28* 85.19 ± 3.12* 86.07 ± 1.88 79.78 ± 1.42 87.87 ± 3.42
†
D2 97.67 ± 5.55 69.99 ± 5.74* 71.95 ± 5.15* 70.66 ± 3.48
† 84.10 ± 1.64 79.19 ± 4.17 72.52 ± 4.94*
D3
†70.90 ± 1.24† 39.73 ± 3.64† 56.93 ± 9.34† 45.08 ± 3.16† 83.72 ± 2.63 76.22 ± 3.28 63.60 ± 4.52†
D4
†55.34 ± 5.71† 21.21 ± 3.14† 47.84 ± 2.60† 30.06 ± 2.59† †66.73 ± 3.44† †51.90 ± 0.99† 53.43 ± 4.26†
*p < 0.05 and †p < 0.01 vs. control group (D0). HR = heart rate; AF = aortic flow; CF = coronary flow; CO = cardiac output; SV = stroke volume.
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with the ischaemic myocardium. Consideration of the dif-
ferences between different solutions, and between adult and
immature hearts with the same solution, may reveal features
of the immature myocardium that could be exploited in the
design of protective interventions.
St. Thomas’ Hospital and Tyers solutions
This study found that both of these solutions afforded a
comparable, high degree of protection in the immature rabbit
heart. These results contrast with those using a similar proce-
dure in the adult rat heart, in which relatively poor protection
was observed when the Tyers solution was used. The reason
for the lack of protection may be attributed to suboptimal
concentrations of both magnesium and calcium. The Tyers
solution contains one tenth of the magnesium and less than
half the calcium of the St. Thomas’ Hospital solution. The
free calcium may be further reduced by the calcium-chelating
properties of the gluconate and acetate components of
the Tyers solution.10 In previous dose-response studies, pro-
tection in the adult myocardium was shown to be highly
dependent on both the calcium and magnesium content of
the St. Thomas’ Hospital solution. The comparable protec-
tion seen in the present studies with the St. Thomas’ Hos-
pital and Tyers solutions might, therefore, suggest that the
neonatal heart has a different responsiveness to these ions
than the adult heart. Confirmation would, of course, require
dose-response studies for each ion in the immature heart.
Studies on isolated rabbit hearts at 37°C by Tomlinson
and Toleikis showed that Tyers solution does not confer good
protection on rabbit myocardium, however, protection af-
forded by KH buffer and St. Thomas’ Hospital no. 2 solution
was much better than that of Tyers solution.11
Bretschneider solution
The results obtained from the Bretschneider solution were
surprising. Kober et al found that this solution can provide
good protection in the adult heart.12 Unlike the “extracellular”
St. Thomas’ Hospital and Tyers solutions, the Bretschneider
solution produces cardiac arrest by reducing the ionic gradi-
ents across the cell membrane. Hence, this “intracellular”
Table 5. Changes in myocardial enzymes in isolated perfused rabbit hearts after a 30-minute period of reperfusion (}X ± S)
Enzymes (IU/L)
GOT LDH CK CK-MB LDH1
Group
D0 14.83 ± 4.62 10.17 ± 1.17 23.00 ± 3.10 10.67 ± 7.00 3.67 ± 1.63
D1 12.00 ± 1.79 11.50 ± 1.87 19.83 ± 2.14 11.83 ± 2.32 3.83 ± 1.47
D2 14.67 ± 1.21 11.50 ± 1.85 21.17 ± 2.32 18.50 ± 5.89 4.50 ± 1.87
D3 †22.17 ± 2.32* †20.00 ± 1.79* †30.00 ± 3.16* †25.33 ± 2.81* 4.83 ± 1.47
D4 †24.83 ± 2.48* †22.50 ± 3.08* †31.00 ± 5.10* †27.83 ± 4.71*
†6.50 ± 1.87†
*p < 0.01 and †p < 0.05 vs. control group (D0). GOT = glutamic oxaloacetic transaminase; LDH = lactate dehydrogenase; CK = creatine
kinase.
Table 4. Changes in myocardial biochemical indices in isolated perfused rabbit hearts after a 30-minute period of reperfusion
(%, }X ± S)
Biochemical indices
ATP ASE GLY MDA
(μmol/g•dry weight) (nmol.Pi/mg•pr•min) (mmol/g) (μmol/g)
Group
D0 1.68 ± 0.11* 3.17 ± 0.09* 4.22 ± 0.21* 1.77 ± 0.09*
D1 1.98 ± 0.54* 4.10 ± 0.13* 4.10 ± 0.12* 1.44 ± 0.12*
D2 1.35 ± 0.39* 4.01 ± 0.14* 3.85 ± 0.09* 1.62 ± 0.15*
D3 0.91 ± 0.16* 3.19 ± 0.25* 3.00 ± 0.32* 2.31 ± 0.18*
D4 0.88 ± 0.10* 0.39 ± 0.08* 1.47 ± 0.19* 5.01 ± 0.19*
*p < 0.01 vs. control group (D0). ATP = adenosine triphosphate; ASE = Na
+K+-ATPase; GLY = glycogen; MDA = maldihydrate.
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solution is characterized by a low sodium content (1.5 mmol/
L), with moderate concentrations of potassium (9.0 mmol/L)
and magnesium (4.0 mmol/L), and is free of calcium. However,
despite rapidly inducing diastolic arrest, the Bretschneider
solution in our present study failed to confer good protection
on the immature myocardium as indicated by poor functional
recovery, poor high phosphate preservation and substantial
enzyme leakage.
In the adult heart, the induction of a calcium paradox is
frequently cited as a potential hazard of acalcaemic cardio-
plegia(s). Damage associated with calcium is characterized by
calcium gain, loss of contractility, extensive enzyme leakage,
and ultrastructural injury. The massive enzyme leakage and
poor ATP preservation during reperfusion in hearts arrested
with Bretschneider solution in this study may suggest a cal-
cium paradox.
Roe solution
The most striking features of the Roe solution are that it
is acalcaemic and has an extremely high concentration of
glucose (278 mmol/L). Metabolism in the immature heart
of a number of species is known to depend predominantly
on glucose. This contrasts with the adult heart, in which fatty
acids represent the primary energy source. It has been sug-
gested that the greater capacity for glucose metabolism
and, in particular, anaerobic glycolysis, confers a greater re-
sistance to ischaemic injury on the immature myocardium.
Conversely, others have suggested that the greater the anaero-
bic glycolytic activity, the greater will be the accumulation
of lactate during ischaemia, and the more rapid will be the
development of tissue acidosis and the onset of irreversible
damage.
In this study, the Roe solution did not afford satisfactory
protection, and this may be attributed, in part, to anaerobic
metabolism during hypothermia (ischaemia). These results
are in line with those of Wilson et al, who found that the
Roe solution did not confer good protection on dogs under-
going cardiopulmonary bypass, with a period of 270 minutes
of ischaemia and 60 minutes of reperfusion at 27°C, as in-
dicated by poor functional recovery.13 The second factor that
may contribute to the very poor recovery of hearts treated
with the Roe solution is the absence of calcium from the
formulation. As with the Bretschneider solution, this might
be expected to predispose the heart to calcium paradox-
like injury. The third factor that might contribute to injury
in hearts treated with the Roe solution is the presence of
tromethamine buffer in the formulation. Tromethamine
penetrates the cell membrane and has been shown to be
toxic in a number of tissues; it should therefore be used with
caution.14
This study showed that all four cardioplegic solutions in-
vestigated markedly affected myocardial ATP, maldihydrate,
glycogen and membrane Na+K+-ATPase, and that these in-
dices changed dramatically (p < 0.05). These results are in line
with those of Podesser et al’s study on the effect of Bretschnei-
der solution on rat myocardial ATP,15 and Wilson et al’s on the
effect of Bretschneider and Roe solutions on dog myocardial
protection.13
Our results showed that, with regard to enzyme leakage,
there were significant differences in groups D3 and D4, but not
in groups D1 and D2, when compared with the control group
D0 (p < 0.01). The greater the enzyme leakage, the poorer the
post-ischaemic recovery of haemodynamics. These results are
in line with those of our previous report, which showed that
St. Thomas’ Hospital no. 2 and Tyers cardioplegic solutions
can limit the leakage of myocardial enzymes.16
In conclusion, in our preparation, good protection was
observed with both the St. Thomas’ Hospital and Tyers
solutions. However, lack of protection and an exacerbation
of injury was observed with both the Bretschneider and Roe
solutions, suggesting perhaps that failure to demonstrate
protective effects of cardioplegic solutions in the neonatal
heart may be attributed in part to the composition of the
solution rather than to a failure of cardioplegia per se. Our re-
sults would appear to favour the use of the extracellular type
of cardioplegic solution, such as the modified St. Thomas’
Hospital no. 1 and Tyers solutions, that rely on a high potas-
sium content to produce arrest, rather than the intracellular
type, such as the Bretschneider and Roe solutions, that uses
zero calcium and low sodium. Although studies in the rabbit
have suggested that substantial changes can occur between
ages 3 and 18 days, and that even greater changes occur
between 18 days and adulthood, it would be premature, on the
basis of this study, to propose that different cardioplegic
solutions be used in adult and neonatal cardiac surgery. The
answer to this question would require detailed studies of
cardioplegic protection over a wide range of age groups.
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